vs

Side-by-side financial comparison of AMERICAN EAGLE OUTFITTERS INC (AEO) and GLOBUS MEDICAL INC (GMED). Click either name above to swap in a different company.

AMERICAN EAGLE OUTFITTERS INC is the larger business by last-quarter revenue ($1.4B vs $826.4M, roughly 1.6× GLOBUS MEDICAL INC). GLOBUS MEDICAL INC runs the higher net margin — 17.0% vs 6.7%, a 10.3% gap on every dollar of revenue. On growth, GLOBUS MEDICAL INC posted the faster year-over-year revenue change (25.7% vs 5.7%). GLOBUS MEDICAL INC produced more free cash flow last quarter ($202.4M vs $-2.5M). Over the past eight quarters, GLOBUS MEDICAL INC's revenue compounded faster (16.7% CAGR vs 2.3%).

American Eagle Outfitters, Inc. is an American clothing and accessories retailer headquartered at SouthSide Works in Pittsburgh, Pennsylvania. It was founded in 1977 by brothers Jerry and Mark Silverman as a subsidiary of Retail Ventures, Inc., a company that also owned and operated Silverman's Menswear. The Silvermans sold half their ownership interests in 1980 to the Schottenstein family and the remainder in 1991. American Eagle Outfitters is the parent company of Aerie, Unsubscribed, and T...

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

AEO vs GMED — Head-to-Head

Bigger by revenue
AEO
AEO
1.6× larger
AEO
$1.4B
$826.4M
GMED
Growing faster (revenue YoY)
GMED
GMED
+20.0% gap
GMED
25.7%
5.7%
AEO
Higher net margin
GMED
GMED
10.3% more per $
GMED
17.0%
6.7%
AEO
More free cash flow
GMED
GMED
$204.9M more FCF
GMED
$202.4M
$-2.5M
AEO
Faster 2-yr revenue CAGR
GMED
GMED
Annualised
GMED
16.7%
2.3%
AEO

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AEO
AEO
GMED
GMED
Revenue
$1.4B
$826.4M
Net Profit
$91.3M
$140.6M
Gross Margin
40.5%
68.4%
Operating Margin
8.3%
20.5%
Net Margin
6.7%
17.0%
Revenue YoY
5.7%
25.7%
Net Profit YoY
14.2%
430.4%
EPS (diluted)
$0.53
$1.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AEO
AEO
GMED
GMED
Q4 25
$1.4B
$826.4M
Q3 25
$1.3B
$769.0M
Q2 25
$1.1B
$745.3M
Q1 25
$598.1M
Q4 24
$1.3B
$657.3M
Q3 24
$1.3B
$625.7M
Q2 24
$1.1B
$629.7M
Q1 24
$1.7B
$606.7M
Net Profit
AEO
AEO
GMED
GMED
Q4 25
$91.3M
$140.6M
Q3 25
$77.6M
$119.0M
Q2 25
$-64.9M
$202.8M
Q1 25
$75.5M
Q4 24
$80.0M
$26.5M
Q3 24
$77.3M
$51.8M
Q2 24
$67.8M
$31.8M
Q1 24
$6.3M
$-7.1M
Gross Margin
AEO
AEO
GMED
GMED
Q4 25
40.5%
68.4%
Q3 25
38.9%
67.2%
Q2 25
29.6%
66.6%
Q1 25
67.3%
Q4 24
40.9%
59.9%
Q3 24
38.6%
56.8%
Q2 24
40.6%
58.7%
Q1 24
36.6%
60.2%
Operating Margin
AEO
AEO
GMED
GMED
Q4 25
8.3%
20.5%
Q3 25
8.0%
17.9%
Q2 25
-7.8%
10.2%
Q1 25
16.2%
Q4 24
8.2%
9.2%
Q3 24
7.8%
7.7%
Q2 24
6.8%
7.9%
Q1 24
0.6%
1.3%
Net Margin
AEO
AEO
GMED
GMED
Q4 25
6.7%
17.0%
Q3 25
6.0%
15.5%
Q2 25
-6.0%
27.2%
Q1 25
12.6%
Q4 24
6.2%
4.0%
Q3 24
6.0%
8.3%
Q2 24
5.9%
5.0%
Q1 24
0.4%
-1.2%
EPS (diluted)
AEO
AEO
GMED
GMED
Q4 25
$0.53
$1.01
Q3 25
$0.45
$0.88
Q2 25
$-0.36
$1.49
Q1 25
$0.54
Q4 24
$0.41
$0.19
Q3 24
$0.39
$0.38
Q2 24
$0.34
$0.23
Q1 24
$0.03
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AEO
AEO
GMED
GMED
Cash + ST InvestmentsLiquidity on hand
$112.8M
$557.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$4.6B
Total Assets
$4.2B
$5.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AEO
AEO
GMED
GMED
Q4 25
$112.8M
$557.2M
Q3 25
$126.8M
$18.8M
Q2 25
$87.9M
Q1 25
Q4 24
$160.2M
$890.1M
Q3 24
$191.8M
$71.9M
Q2 24
$300.5M
$82.5M
Q1 24
$454.1M
$80.4M
Total Debt
AEO
AEO
GMED
GMED
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$0
Stockholders' Equity
AEO
AEO
GMED
GMED
Q4 25
$1.6B
$4.6B
Q3 25
$1.5B
$4.4B
Q2 25
$1.5B
$4.3B
Q1 25
$4.1B
Q4 24
$1.7B
$4.2B
Q3 24
$1.7B
$4.1B
Q2 24
$1.8B
$4.0B
Q1 24
$1.7B
$3.9B
Total Assets
AEO
AEO
GMED
GMED
Q4 25
$4.2B
$5.3B
Q3 25
$4.1B
$5.1B
Q2 25
$3.8B
$5.0B
Q1 25
$4.7B
Q4 24
$3.7B
$5.3B
Q3 24
$3.5B
$5.1B
Q2 24
$3.6B
$5.0B
Q1 24
$3.6B
$4.9B
Debt / Equity
AEO
AEO
GMED
GMED
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AEO
AEO
GMED
GMED
Operating Cash FlowLast quarter
$67.1M
$248.6M
Free Cash FlowOCF − Capex
$-2.5M
$202.4M
FCF MarginFCF / Revenue
-0.2%
24.5%
Capex IntensityCapex / Revenue
5.1%
5.6%
Cash ConversionOCF / Net Profit
0.74×
1.77×
TTM Free Cash FlowTrailing 4 quarters
$-169.8M
$588.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AEO
AEO
GMED
GMED
Q4 25
$67.1M
$248.6M
Q3 25
$27.8M
$249.7M
Q2 25
$-54.7M
$77.9M
Q1 25
$177.3M
Q4 24
$52.9M
$210.3M
Q3 24
$78.3M
$203.7M
Q2 24
$-38.1M
$54.3M
Q1 24
$296.4M
$52.4M
Free Cash Flow
AEO
AEO
GMED
GMED
Q4 25
$-2.5M
$202.4M
Q3 25
$-43.1M
$213.9M
Q2 25
$-116.3M
$31.3M
Q1 25
$141.2M
Q4 24
$-7.8M
$193.2M
Q3 24
$17.5M
$161.7M
Q2 24
$-74.3M
$26.5M
Q1 24
$256.8M
$23.8M
FCF Margin
AEO
AEO
GMED
GMED
Q4 25
-0.2%
24.5%
Q3 25
-3.4%
27.8%
Q2 25
-10.7%
4.2%
Q1 25
23.6%
Q4 24
-0.6%
29.4%
Q3 24
1.4%
25.8%
Q2 24
-6.5%
4.2%
Q1 24
15.3%
3.9%
Capex Intensity
AEO
AEO
GMED
GMED
Q4 25
5.1%
5.6%
Q3 25
5.5%
4.7%
Q2 25
5.7%
6.2%
Q1 25
6.0%
Q4 24
4.7%
2.6%
Q3 24
4.7%
6.7%
Q2 24
3.2%
4.4%
Q1 24
2.4%
4.7%
Cash Conversion
AEO
AEO
GMED
GMED
Q4 25
0.74×
1.77×
Q3 25
0.36×
2.10×
Q2 25
0.38×
Q1 25
2.35×
Q4 24
0.66×
7.94×
Q3 24
1.01×
3.93×
Q2 24
-0.56×
1.71×
Q1 24
46.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AEO
AEO

American Eagle Brand$800.4M59%
Aerie Brand$429.1M31%
Other$133.2M10%

GMED
GMED

Other$391.8M47%
Nevro Merger Agreement$293.6M36%
Enabling Technologies$141.0M17%

Related Comparisons